132 related articles for article (PubMed ID: 35476625)
1. Letter Regarding "Delayed-onset Anaphylaxis After COVID-19 Vaccination".
Mungmunpuntipantip R; Wiwanitkit V
Pediatr Infect Dis J; 2022 Aug; 41(8):e342. PubMed ID: 35476625
[No Abstract] [Full Text] [Related]
2. Delayed-onset Anaphylaxis After mRNA-Based COVID-19 Vaccination in an Adolescent Male.
Shrestha P; Bhattarai S; Dhungana J; Bhattarai T
Pediatr Infect Dis J; 2022 Jun; 41(6):e271. PubMed ID: 35389949
[No Abstract] [Full Text] [Related]
3. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
Azenha Rama T; Álvarez-Twose I
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
[No Abstract] [Full Text] [Related]
4. Anaphylaxis after COVID-19 vaccination: A registry-based study.
Jaggers J; Samarakoon U; Fu X; Gonzalez-Estrada A; Anvari S; Chong HJ; Van Meerbeke SW; Petrov AA; Chow TG; Banerji A; Judd A; Blumenthal KG
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):3020-3023. PubMed ID: 35964925
[No Abstract] [Full Text] [Related]
5. Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis.
Yoon D; Kim JH; Jeong HE; Ko HY; Kim SR; Shin JY;
Allergy; 2024 Mar; 79(3):754-757. PubMed ID: 38084802
[No Abstract] [Full Text] [Related]
6. [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].
Worm M; Ring J; Klimek L; Jakob T; Lange L; Treudler R; Beyer K; Werfel T; Biedermann T; Bircher A; Fischer M; Fuchs T; Heller AR; Hoffmann F; Huttegger I; Kopp MV; Kugler C; Lommatzsch M; Pfaar O; Rietschel E; Rueff F; Schnadt S; Seifert R; Stöcker B; Vogelberg C; Sitter H; Gieler U; Brockow K
MMW Fortschr Med; 2021 Jan; 163(1):48-51. PubMed ID: 33464512
[No Abstract] [Full Text] [Related]
7. Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines.
Kelso JM
Ann Allergy Asthma Immunol; 2021 Jul; 127(1):133-134. PubMed ID: 33781933
[No Abstract] [Full Text] [Related]
8. Anaphylaxis: Revision of the Brighton collaboration case definition.
Gold MS; Amarasinghe A; Greenhawt M; Kelso JM; Kochhar S; Yu-Hor Thong B; Top KA; Turner PJ; Worm M; Law B
Vaccine; 2023 Apr; 41(15):2605-2614. PubMed ID: 36435707
[TBL] [Abstract][Full Text] [Related]
9. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
10. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Zhou ZH; Cortese MM; Fang JL; Wood R; Hummell DS; Risma KA; Norton AE; KuKuruga M; Kirshner S; Rabin RL; Agarabi C; Staat MA; Halasa N; Ware RE; Stahl A; McMahon M; Browning P; Maniatis P; Bolcen S; Edwards KM; Su JR; Dharmarajan S; Forshee R; Broder KR; Anderson S; Kozlowski S
Vaccine; 2023 Jun; 41(28):4183-4189. PubMed ID: 37244808
[TBL] [Abstract][Full Text] [Related]
11. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
12. [COVID-19 vaccines increase the risk of anaphylaxis].
Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
[No Abstract] [Full Text] [Related]
13. Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria.
Park HJ; Montgomery JR; Boggs NA
Mil Med; 2022 Dec; 187(9):e1556-e1558. PubMed ID: 33851711
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine concerns of health care providers and ancillary staff.
Lewin BJ; Bronstein D; Tubert JE; Chang J; Luo YX; Choi KR; Munoz-Plaza C; Rondinelli JL; Bruxvoort K
Pediatr Res; 2023 Feb; 93(3):460-462. PubMed ID: 35717481
[TBL] [Abstract][Full Text] [Related]
15. Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021.
Shivarev A; Phillips A; Brophy-Williams S; Ford T; Richmond P; Effler P; McLean-Tooke A
Intern Med J; 2023 Feb; 53(2):275-279. PubMed ID: 36585764
[TBL] [Abstract][Full Text] [Related]
16. The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
Bigini P; Gobbi M; Bonati M; Clavenna A; Zucchetti M; Garattini S; Pasut G
Nat Nanotechnol; 2021 Nov; 16(11):1169-1171. PubMed ID: 34732846
[No Abstract] [Full Text] [Related]
17. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
[TBL] [Abstract][Full Text] [Related]
18. Maintaining Safety with SARS-CoV-2 Vaccines.
Castells MC; Phillips EJ
N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
[No Abstract] [Full Text] [Related]
19. Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis.
Pienkowski MM; Pienkowski SM
Ann Allergy Asthma Immunol; 2022 Jan; 128(1):101-103. PubMed ID: 34601091
[No Abstract] [Full Text] [Related]
20. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.
Shimabukuro T
Am J Transplant; 2021 Mar; 21(3):1326-1331. PubMed ID: 33641268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
